# Lexia LLC – FDA Inspection, Sep 29, 2025

Source: https://www.keypedia.com/records/fda_inspections/lexia-llc/1c42bb59-a8ac-4aa9-9303-f20790ec2e7f
Source feed: FDA_Inspections

> FDA inspection 1284722 of Lexia LLC, September 29, 2025. Classification: Official Action Indicated (OAI). 8 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1284722
- Company Name: Lexia LLC
- Inspection Date: 2025-09-29
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Orleans District Office
- Citation Count: 8

## Related Documents

- [FDA Inspection 1081647 - 2019-03-07](https://www.keypedia.com/records/fda_inspections/lexia-llc/7fa9b4c4-a638-40ec-9a0d-63849b40bcf5)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/inga-m-warr/f27805b8-c2ba-4af5-bf5e-ff2e2f511ec1)

Company: https://www.keypedia.com/companies/lexia-llc/7f29fe6a-68bf-4b1d-906d-4d1c093efde4

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea
